Veradigm and CareMetx Partner to Optimize Specialty Medication Access

Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions, and CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced a new agreement for CareMetx to integrate its solutions and services directly into the Veradigm AccelRx® specialty medication platform.

Patient support programs are a key for treatment success for specialty drugs. Patient access and adherence to specialty medications often can be limited by their complexity and high cost.

Many hub service providers and other companies develop patient support platforms to offer patient-centric capabilities in order to provide better services that improve patient outcomes.

These programs often serve as a key resource for patients beginning a specialty therapy. The success of a patient engagement solution is its ability to initiate actual results in care for patients.

The agreement will make Veradigm’s AccelRx automated solutions for specialty medication enrollment, among others, available directly to CareMetx clients. Empowering users of Veradigm and Allscripts® electronic health records to access CareMetx specialty medication patient access hub services via AccelRx.

This combination strengthens the ability to reduce time to therapy for patients, thereby driving higher adherence to their prescribed care plan, while also minimizing administrative burden on medical practices.

Serving pharmaceutical, biotechnology and device manufacturers, CareMetx leverages a digital hub platform to provide efficient delivery of eServices. CareMetx leadership in patient access promotes efficiency in the healthcare ecosystem, removing barriers for patients and providers alike.


Takeaway: Reducing time-to-therapy for specialty medication remains the goal of hub service providers